Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

The Botanicals Podcast

Dec 17 2021 | 00:13:40

00:00 / 00:13:40

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

Other Episodes

Episode 1

May 07, 2020 • 00:15:55

JLN checks in with Supercritical on banking relief and a scramble for new canna licenses

In the latest JLN update on the legal cannabis marketplace, Thom Thompson interviews Sparky Rose and Kerry Jordan, principals of the consultancy Supercritical, about...

Episode 0

July 28, 2020 • 00:17:10

Publicly Traded Cannabis Stocks See Volume, Volatility as Sector Matures

Saleem Daya, analyst with Nasdaq IR Intelligence in Toronto, breaks down early 2020 trends in cannabis-related stocks for John Lothian News, and talks about...

Episode 0

March 15, 2021 • 00:17:15

Retail Traders Wade Into Cannabis Shares, Add Volatility

Nasdaq IR Intelligence analyst Saleem Daya sat down to talk with JLN about a recent jump in cannabis stock price volatility. He also explained...